An observational study in Sarcoma and Melanoma, sponsored by Royal Marsden NHS Foundation Trust. Completed at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-05-23.
Sponsored by Royal Marsden NHS Foundation Trust · Observational
The primary objective of this research project is to estimate the number of patients with sarcoma or melanoma attending an outpatients clinic that are in pain or have unmet pain needs.
3,005 studies on the registry are indexed under Melanoma; 519 are open to participants now.
This study's enrollment of 250 is above the median of 182 across 438 observational studies indexed under Melanoma.
Browse Melanoma studies →Royal Marsden NHS Foundation Trust is the lead sponsor of 262 studies on the registry; 49 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Participants attending sarcoma and melanoma out patients clinics at the Royal Marsden Hospital.
Exclusion Criteria:
The proportion of patients with significant pain and the proportion of patients with a negative score on the pain management index (PMI)
Proportion of patients with neuropathic pain.
Potential predictors of pain. The variables tested as potential risk factors will be age, tumour type, gender and treatment type.
We will also seek to identify potential predictors of pain intensity in patients that do have pain. In addition to the risk factors already mentioned above, duration and cause of pain will also be tested in this case as potential pain predictors.
This study is completed, as verified in May 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Royal Marsden NHS Foundation Trust